MartinDouglasPhillipsMD

PubMed

• 7 citations
  Inhibition of the stem cell factor 248 isoform attenuates the development of pulmonary remodeling disease.
  Andrew J. Rasky, David M. Habiel, Susan B. Morris, Matthew Schaller, Bethany B. Moore, Sem H. Phan, Steven L. Kunkel, Martin Phillips, Cory M. Hogaboam, Nicholas W. Lu...> ;American Journal of Physiology. Lung Cellular and Molecular Physiology. 2020 Jan 1
• 19 citations
  Group 2 innate lymphoid cells (ILC2) are regulated by stem cell factor during chronic asthmatic disease.
  Wendy Fonseca, Andrew J. Rasky, Catherine Ptaschinski, Susan H. Morris, Shannon K.K. Best, Martin Phillips, Carrie-Anne Malinczak, Nicholas W. Lukacs> ;Mucosal Immunology. 2019 Jan 7
• 103 citations
  Farletuzumab (a monoclonal antibody against folate receptor alpha) in relapsed platinum-sensitive ovarian cancer.
  Deborah K. Armstrong, Allen J. White, Susan C. Weil, M. Phillips, Robert L. Coleman> ;Gynecologic Oncology. 2013 Jun 1
• A phase I study of MORAb-003, a humanized monoclonal antibody against folate receptor alpha, in advanced epithelial ovarian cancer.
  Bell-McGuinn KM, Konner JA, Pandit-Taskar N, Larson SM, Gerst SR, VanderEls N, Old L, Weil S, Phillips M, Aghajanian CA> ;J. Clin. Oncol.. 2008-05-20
• A phase I study of MORab-009, a monoclonal antibody against mesothelin, in mesothelioma, pancreatic and ovarian cancer.
  Laheru DA, Cohen SJ, Phillips M, Armstrong DK, Brahmer J, Jaffee EM, Weil S, Pastan I, Hassan R> ;J. Clin. Oncol.. 2008-05-20
• 27 citations
  Characterization of a novel autosomal dominant bleeding disorder in a large kindred from east Texas.
  Shao Qing Kuang, Sumera N. Hasham, Martin D. Phillips, David S. Wolf, Ying Wan, Perumal Thiagarajan, Dianna M. Milewicz> ;Blood. 2001 Mar 15
• Farletuzumab, a humanized monoclonal antibody against folate receptor alpha, in epithelial ovarian cancer: a phase I study.
  Konner, J. A., Bell-McGuinn, K. M., Sabbatini, P., Hensley, M. L., Tew, W. P., Pandit-Taskar, N., Vander Els, N., Phillips, M. D., Schweizer, C., Weil, S. C., Larson, ...> ;Clin Cancer Res. 2010 Nov 1
• Preclinical evaluation of MORAb-009, a chimeric antibody targeting tumor-associated mesothelin.
  Hassan, R., Ebel, W., Routhier, E. L., Patel, R., Kline, J. B., Zhang, J., Chao, Q., Jacob, S., Turchin, H., Gibbs, L., Phillips, M. D., Mudali, S., Iacobuzio-Donahue,...> ;Cancer Immun. 2007
• Preclinical evaluation of MORAb-003, a humanized monoclonal antibody antagonizing folate receptor-alpha.
  Ebel, W., Routhier, E. L., Foley, B., Jacob, S., McDonough, J. M., Patel, R. K., Turchin, H. A., Chao, Q., Kline, J. B., Old, L. J., Phillips, M. D., Nicolaides, N. C....> ;Cancer Immun. 2007
• Join now to see all